Industry participants in a recently launched collaboration with FDA hope the effort will lead to more predictable and transparent postmarket enforcement actions.
Last fall, twenty-eight people from the medical device industry, FDA and the Association for the Advancement of Medical Instrumentation (AAMI) came together in a working group with the goal of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?